Status:
COMPLETED
Metabolic Syndrome in PCOS: Precursors and Interventions
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Polycystic Ovary Syndrome
Metabolic Syndrome
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the metabolic effects of anti-androgens and oral contraceptive pills (OCPs), compared with placebo, in the treatment of women with PCOS. We hypothesized tha...
Detailed Description
Polycystic ovary syndrome (PCOS) is one of the most common conditions of young women, and it is frequently associated with insulin resistance or metabolic syndrome (MBS). In addition, affected women h...
Eligibility Criteria
Inclusion
- 6 periods or fewer per year
- Overweight
- All ethnicities
Exclusion
- Diabetes
- Heart Disease
- Chronic illness
- Regular Smokers
- Current use of Birth Control Pills, Patch, Ring, Depo
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00442689
Start Date
July 1 2006
End Date
November 1 2012
Last Update
June 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611